Cargando…
Research in the Field of Drug Design and Development
The processes used by academic and industrial scientists to discover new drugs have recently experienced a true renaissance, with many new and exciting techniques being developed over the past 5–10 years alone. Drug design and discovery, and the search for new safe and well-tolerated compounds, as w...
Autores principales: | Biala, Grazyna, Kedzierska, Ewa, Kruk-Slomka, Marta, Orzelska-Gorka, Jolanta, Hmaidan, Sara, Skrok, Aleksandra, Kaminski, Jakub, Havrankova, Eva, Nadaska, Dominika, Malik, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536713/ https://www.ncbi.nlm.nih.gov/pubmed/37765091 http://dx.doi.org/10.3390/ph16091283 |
Ejemplares similares
-
New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022) -
Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice
por: Kruk-Slomka, Marta, et al.
Publicado: (2021) -
The Importance of l-Arginine:NO:cGMP Pathway in Tolerance to Flunitrazepam in Mice
por: Talarek, Sylwia, et al.
Publicado: (2016) -
Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice
por: Kruk-Slomka, Marta, et al.
Publicado: (2019) -
Inhibitors of Endocannabinoids’ Enzymatic Degradation as a Potential Target of the Memory Disturbances in an Acute N-Methyl-D-Aspartate (NMDA) Receptor Hypofunction Model of Schizophrenia in Mice
por: Kruk-Slomka, Marta, et al.
Publicado: (2023)